Seletracetam
| Disease area studied | Abbreviated title | Phase | Study ID | Registry database | Study results | Plain language summary | Publication (if available) |
|---|---|---|---|---|---|---|---|
| Epilepsy | Phase 2 |
N01191
Completed |
NCT00152451 | ||||
| Epilepsy | Phase 2 |
N01192
Completed |
NCT00152503 | ||||
| Epilepsy | Phase 3 |
N01197
Terminated |
NCT00175851 | ||||
| Epilepsy | Phase 2 |
N01272
Terminated |
NCT00422110 |